| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $113.6M | — | +88.3% |
| Cost of Revenue | $46.6M | — | +55.5% |
| Gross Profit | $67.0M | — | +120.7% |
| R&D Expense | $32.7M | — | +9.0% |
| SG&A Expense | $38.9M | — | +45.0% |
| Operating Income | -$12.3M | — | +56.1% |
| Pre-tax Income | -$5.2M | — | +78.1% |
| Income Tax | $14K | — | -79.1% |
| Net Income | -$5.2M | — | +78.2% |
| EPS (Basic) | -$0.20 | — | +80.2% |
| EPS (Diluted) | -$0.20 | — | +80.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $55.0M | +22.1% | +95.6% |
| Inventory | $91.1M | +11.7% | +10.3% |
| Current Assets | $949.2M | -0.0% | +82.8% |
| Total Assets | $1.29B | -0.1% | +48.2% |
| Current Liabilities | $76.1M | -9.4% | -28.7% |
| Total Liabilities | $133.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $31.2M | — | +107.4% |
| Capital Expenditures | $13.3M | — | -18.4% |
| Investing Cash Flow | $483.7M | — | +1236.4% |
| Financing Cash Flow | -$33.1M | — | -79.3% |
| Free Cash Flow | $17.9M | — | +1500.4% |
| -25.5% |
| Stockholders' Equity | $1.16B | +0.2% | +67.4% |